2'-Fucosyllactose (2'-FL HMO) — The Infant Formula Atlas

By María López Botín · Mother of 2, researching infant formula and infant nutrition since 2018

2'-fucosyllactose is the most talked-about human milk oligosaccharide (HMO) in infant formula, and with good reason. HMOs are a class of complex carbohydrates unique to breast milk, over 200 distinct structures have been identified, and they serve as prebiotics, immune modulators, and direct antimicrobials in the infant gut. For decades, formula couldn't include HMOs because we didn't know how to produce them industrially. In 2016 that changed: microbial fermentation made 2'-FL commercially available, and it became the first HMO in infant formula. It is structurally bioidentical to the 2'-FL in breast milk, it dominates the total HMO content in most mothers' milk, and it is now present in a growing number of US formulas.

What HMOs are and why they matter

Breast milk is roughly 88% water, 7% carbohydrate, 4% fat, and 1% protein. Of the 7% carbohydrate, about 90% is lactose (energy for the infant) and 10% is oligosaccharides, the HMOs. These HMOs are not digested by the infant. They pass intact through the small intestine and reach the colon, where three things happen:

Selective feeding of Bifidobacterium infantis and related HMO-specialist bacteria. B. infantis has specific enzymes to break down HMO structures, giving it a competitive advantage in the breastfed infant's colon.
Pathogen decoy action. HMO structures resemble the sugars on infant gut cell surfaces. Pathogenic bacteria (certain E. coli, Campylobacter, some viruses) bind HMOs instead of binding to the gut wall, and get flushed out.
Direct immune modulation. HMOs signal to gut-associated lymphoid tissue, shaping the developing immune response.

Infants fed only standard formula have historically had lower Bifidobacterium counts and higher infection rates than breastfed infants. Adding HMOs, or structural analogs like GOS/FOS, partially closes this gap.

Human milk oligosaccharide (HMO) family structure showing 2'-fucosyllactose (2'-FL) as the most studied and commercially available HMO, with its position among the 200 and HMO compounds in breast milk — Breast milk contains 200 and distinct HMOs at 5-15 g/L, the third most abundant component after lactose and lipids. 2'-FL is the most abundant and most-studied. Infant formulas currently add 2'-FL (some add 6'-SL, LNnT, 3'-SL) but recreate only a fraction of breast-milk complexity.

What 2'-FL is specifically

Of the 200 and HMOs in breast milk, 2'-fucosyllactose is typically the most abundant, making up 20–30% of total HMO content in the milk of women who produce it. Its structure is a lactose backbone with a fucose sugar attached at the 2' position of the galactose unit.

Industrial 2'-FL is produced via microbial fermentation, genetically engineered E. coli or Corynebacterium strains that express the relevant fucosyltransferase enzymes, fed with lactose and fucose substrates. The output is purified 2'-FL identical in structure to the human milk version.

The EU and US have both approved 2'-FL as safe for use in infant formula. EFSA in 2015, FDA GRAS notification in 2016.

How 2'-FL differs from GOS and FOS

European organic formulas typically use GOS plus FOS at a 9:1 ratio. US premium formulas increasingly use 2'-FL instead or in addition. The practical differences:

Structural fidelity. 2'-FL is a direct copy of a specific HMO. GOS is structurally related but not identical. FOS is further removed structurally.
Cost. 2'-FL is substantially more expensive per gram than GOS or FOS — roughly 10-50x depending on supplier. This is why it tends to appear in premium or specialty formulations.
Breadth. GOS, FOS covers shorter, and longer oligosaccharides. 2'-FL is one specific structure. Newer formulas combine 2'-FL with GOS and FOS to get breadth plus fidelity.
Selectivity. 2'-FL selectively feeds HMO-specialist bacteria (B. infantis); GOS/FOS feeds a broader set of Bifidobacterium species.

Neither approach is clearly superior. Both have documented benefits on infant gut microbiome composition and modest evidence on infection rates.

Which formulas use 2'-FL

In the US market:

Similac Pro-Advance, Pro-Sensitive, Pro-Total Comfort: Abbott led US adoption of 2'-FL.
Enfamil Enspire, Enfamil NeuroPro: Reckitt's 2'-FL-fortified lines.
ByHeart Whole Nutrition, includes 5 different HMOs including 2'-FL.
Bobbie, added 2'-FL to specific variants in recent reformulations.
Gerber Good Start, adds 2'-FL in the Gentle line.

In the EU organic space:

2'-FL adoption is slower. Most EU organic brands (HiPP Dutch, Holle, Kendamil, Lebenswert) still use GOS or GOS and FOS as their primary prebiotic.
Some newer lines from brands like Aptamil include 2'-FL alongside GOS.
Specialty hypoallergenic formulas occasionally add 2'-FL for its immune effects in sensitive infants.

Our Infant Formula Atlas cross-references the prebiotic approach per SKU. A parent optimizing for HMO content specifically will find more US options than EU options currently, though the European space is evolving.

Evidence for clinical benefits

2'-FL has been studied more intensively in the last decade than any other single formula additive:

Safety and tolerance. Extensively documented. No adverse effects at tested doses.
Growth and feeding outcomes. Formulas with 2'-FL support normal growth equivalent to non-supplemented formula and breastfed controls.
Infection rates. Some trials show reduced respiratory and GI infections in 2'-FL groups vs controls. Effects are modest and not universal.
Immune markers. 2'-FL fed infants show cytokine profiles and white blood cell compositions closer to breastfed infants than to non-HMO formula-fed controls.
Bifidobacterium dominance. Measurably increases, especially B. infantis.

What to make of all this

For a parent choosing between formulas:

Both GOS and FOS (European standard) and 2'-FL HMO (US premium) are good choices. They achieve similar outcomes through different mechanisms.
Neither is necessary. Healthy infants can grow on formulas without prebiotics, though the gut microbiome pattern will differ from breastfed infants.
Combined formulations (GOS and FOS and 2'-FL) are the most expensive but probably the closest overall match to breast milk's oligosaccharide profile. ByHeart's 5-HMO formula goes furthest in this direction.
If you specifically want HMO content, look for 2'-FL on the US side or the newer HMO-fortified European lines. Plain GOS/FOS alone does not include actual human milk oligosaccharides, though it functions similarly.

Frequently asked questions

What is 2'-FL HMO?

2'-fucosyllactose (2'-FL) is the most abundant Human Milk Oligosaccharide (HMO) in breast milk — making up roughly 30% of total HMO content. HMOs are complex carbohydrates that resist infant digestion, instead feeding beneficial gut bacteria (especially Bifidobacterium infantis) and acting as decoys against pathogens. 2'-FL specifically is the form that's now produced commercially via biotechnology (microbial fermentation) and added to infant formulas. It's chemically identical to the 2'-FL in breast milk.

Is 2'-FL the same as the HMO in breast milk?

Chemically yes — commercial 2'-FL produced via microbial fermentation is structurally identical to breast milk 2'-FL. However, breast milk contains 200+ different HMO molecules; 2'-FL alone is just one of them (the most abundant). Multi-HMO formulas (Enfamil NeuroPro 5-HMO, ByHeart) include several HMO species to better approximate breast milk's HMO diversity. Single-2'-FL formulas (Similac Pro-Advance, HiPP HMO) provide the most abundant HMO but don't replicate the full HMO profile.

Which infant formulas contain 2'-FL HMO?

On the US side: Similac Pro-Advance, Enfamil NeuroPro (and NeuroPro 5-HMO with multiple HMOs), Bobbie (with 2'-FL added), ByHeart Whole Nutrition (5-HMO blend). On the EU side: HiPP HA Combiotik with HMO, Aptamil Profutura (5-HMO in some markets), Nutrilon Profutura. Most premium tier formulas now include at least 2'-FL; basic mass-market formulas typically don't. The Atlas SKU records document HMO presence per product.

Is 2'-FL HMO the same as GOS or FOS?

No — they're different categories of prebiotic. GOS (galacto-oligosaccharides) and FOS (fructo-oligosaccharides) are commercial prebiotics derived from lactose and chicory root respectively. They mimic some prebiotic functions of HMOs but are NOT structurally HMOs. 2'-FL is an actual HMO present in breast milk. Premium formulas combine GOS+FOS prebiotic blend (the EU regulatory standard) with added 2'-FL HMO for the most comprehensive prebiotic profile.

Is 2'-FL clinically proven beneficial?

Yes, modestly. Clinical trials show 2'-FL-supplemented formulas produce stool patterns and microbiome composition closer to breast-fed infants vs unsupplemented formulas. There are some studies suggesting reduced respiratory infection rates in 2'-FL-fed infants. The effect size is modest but real. AAP and pediatric organizations recognize HMO supplementation as beneficial; FDA reviewed and approved the safety of 2'-FL for infant formula use in 2015. Not yet regulatory-mandated but increasingly standard in premium formulas.

Is 2'-FL HMO worth the premium price?

Depends on context. For most healthy term infants, FDA-registered formulas without HMO still produce normal growth and development. The 2'-FL HMO benefit is incremental — closer-to-breast-milk microbiome, possibly modest infection-rate reduction. Families optimizing for breast-milk-similar nutrition may find 2'-FL worth the modest premium ($5-10/tin). Budget-constrained families can use non-HMO FDA-registered formulas without compromising safety. For premature infants or those with specific health concerns, pediatrician guidance matters more than HMO presence.

Primary sources

Reverri EJ et al. Review of the clinical experiences of feeding infants formula containing the human milk oligosaccharide 2'-fucosyllactose. Nutrients, 2018. pubmed.ncbi.nlm.nih.gov/28052285
EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the safety of 2'-O-fucosyllactose as novel food, EFSA Journal 2015. efsa.europa.eu
Marriage BJ et al. Infants fed a lower calorie formula with 2'-FL show growth and 2'-FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr, 2015. pubmed.ncbi.nlm.nih.gov/29493465
US FDA. GRAS notification for 2'-fucosyllactose. fda.gov

Brands and comparisons featuring 2'-FL HMO, Similac Pro-Advance vs Enfamil NeuroPro (the HMO-strategy comparison), Similac brand hub (2'-FL single-HMO positioning), Enfamil brand hub (HuMO6 blend)
How formula brands compare, bioactives
FDA vs EFSA standards compared
Infant microbiome and formula choice, what the evidence shows

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.

Formulas containing 2'-fucosyllactose (2'-fl hmo)

Primary sources